Abstract
The figure of 80% is classically quoted as the percentage of patients with advanced prostatic adenocarcinoma who respond at least initially to hormonal manipulation. At the present time there is no method of predicting whether a given patient will respond to such therapy. It is not unreasonable to hypothesize that those patients with androgen dependent tumors should have high levels of androgen binding sites. A non-immunologic histochemical method has been developed by Pertschuk (1,2,3,4,5) to measure androgen binding sites. The principal purpose of this report is to update the clinical trial we are currently conducting to determine whether or not the test can be used to predict response to hormonal manipulation.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
L.P. Pertschuk, D.T. Zava, E. Gaetjens, R.J. Macchia, D.J. Brigati, and D.S. Kim, Detection of androgen and estrogen receptors in human prostatic carcinoma and hyperplasia by fluorescence microscopy, Res. Comm. Path. Pharmacol. 22:427 (1978).
L.P. Pertschuk, D.T. Zava, E. Gaetjens, R.J. Macchia, G.J. Wise, D.S. Kim, and D.J. Brigati, Histochemistry of steroid receptors in prostatic disease, Ann. Clin. Lab. Sci. 9:225 (1979).
L.P. Pertschuk, D.T. Zava, E.H. Tobin, D.J. Brigati, E. Gaetjens, R.J. Macchia, G.J. Wise, H.S. Wax, and D.S. Kim, Histochemical detection of steroid hormone receptors in the human prostate, in: “Prostate Cancer and Hormone Receptors,” G.P. Murphy and A.A. Sandberg, eds., Alan R. Liss, Inc., New York (1979).
L.P. Pertschuk, E.H. Tobin, P. Tanapat, E. Gaetjens, A.C. Carter, N.D. Bloom, R.J. Macchia, and K.B. Eisenberg, Histochemical analyses of steroid hormone receptors in breast and prostatic carcinoma, J. Histochem. Cytochem. 28:799 (1980).
L.P. Pertschuk, H.E. Rosenthal, R.J. Macchia, K.B. Eisenberg, J.G. Feldman, S.H. Wax, D.S. Kim, W.F. Whitmore, Jr., J.I. Abrahams, E. Gaetjens, G.J. Wise, H.W. Herr, J.P. Karr, G.P. Murphy, and A.A. Sandberg, Correlation of histochemical and biochemical analyses of androgen binding in prostatic cancer: relation to therapeutic response, Cancer, in press.
J.D. Schmidt, D.E. Johnson, W.W. Scott, R.P. Gibbons, G.R. Prout, Jr., and G.P. Murphy, Chemotherapy of advanced prostatic cancer, evaluation of response parameters, Urology 7:602 (1976).
E. Gaetjens and L.P. Pertschuk, Synthesis of fluorescent labeled-steroid hormone albumin conjugates for the histochemical detection of hormone receptors, J. Steroid Biochem. 13:1121 (1980).
D.R. Gleason, Histologic grading and clinical staging of prostatic carcinoma, in: “Urologic Pathology: The Prostate,” M. Tannenbaum, ed., Lea and Febiger, Philadelphia (1977).
R.J. Boxer, Adenocarcinoma of the prostate gland, Urol. Surv. 27:75 (1977).
Author information
Authors and Affiliations
Consortia
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Macchia, R.J., Pertschuk, L.P., New York Prostate Binding Site Study Group. (1983). Histochemical Determination of Androgen Binding Sites in Prostatic Adenocarcinoma: Clinical Correlation. In: Pavone-Macaluso, M., Smith, P.H. (eds) Cancer of the Prostate and Kidney. NATO Advanced Science Institutes Series, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4349-3_30
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4349-3_30
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4351-6
Online ISBN: 978-1-4684-4349-3
eBook Packages: Springer Book Archive